Identification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosis

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 756-767

  Kurosu, Katsushi ^a   Takiguchi, Yuichi ^a   Okada, Osamu ^a   Yumoto, Norio ^a   Sakao, Seiichiro ^a   Tada, Yuji ^a   Kasahara, Yasunori ^a   Tanabe, Nobuhiro ^a   Tatsumi, Koichiro ^a   Weiden, Michael ^b   Rom, William N ^b   Kuriyama, Takayuki ^a  

^a CHIBA UNIVERSITY   (Japan)

^b University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; ANNEXIN 1; AUTOANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG; ANTIBODY; COMPLEMENTARY DNA; LYMPHOCYTE ANTIGEN RECEPTOR; PANCREATIC ELASTASE; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; PATHOGENESIS; PRIORITY JOURNAL; WESTERN BLOTTING; ACUTE DISEASE; AGED; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG FIBROSIS; MALE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ACUTE DISEASE; AGED; ANNEXINS; ANTIBODIES; AUTOANTIGENS; BASE SEQUENCE; BRONCHOALVEOLAR LAVAGE FLUID; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PANCREATIC ELASTASE; PULMONARY FIBROSIS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT PROTEINS;

EID: 47949115533     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.756     Document Type: Article

References (48)

1. Hunninghake, G. W., M. B. Zimmerman, D. A. Schwartz, T. E. King, Jr., J. Lynch, R. Hegele, J. Waldron, T. Colby, N. Muller, D. Lunch, et al. 2001. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med 164: 193-196.
2. Kondoh, Y., H. Taniguchi, Y. Kawabata, K. Suzuki, and K. Takagi. 1993. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases. Chest 103: 1808-1812.
3. Ambrosini, V., A. Cancellieri, M. Chilosi, M. Zompatori, R. Trisolini, L. Saragoni, and V. Poletti. 2003. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur. Respir. J. 22: 821-826.
4. Wallace, W. A., S. N. Roberts, H. Caldwell, E. Thornton, A. P. Greening, D. Lamb, and S. E. Howie. 1994. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. Thorax 49: 218-222.
5. Wallace, W. A., J. A. Schofield, D. Lamb, and S. E. Howie. 1994. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax 49: 1139-1145.
6. Dobashi, N., J. Fujita, Y. Ohtsuki, I. Yamadori, T. Yoshinouchi, T. Kamei, M. Tokuda, S. Hojo, and J. Takahara. 1998. Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders. Thorax 53: 969-974.
7. Yu, W., K. J. Han, X. W. Pang, H. A. Vaughan, W. Qu, X. Y. Dong, J. R. Peng, II. T. Zhao, J. A. Rui, X. S. Leng, et al. 2002. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J. Immunol. 169: 1102-1109.
8. Eichmuller, S., D. Usener, R. Dummer, and A. Stein. 2001. Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc. Natl. Acad. Sci. USA 98: 629-634.
9. Jeoung, D. I., E. B. Lee, S. Lee, Y. Lim, D. Y. Lee, J. Kim, H. Y. Kim, and Y. W. Song. 2002. Autoantibody to DNA binding protein B as a novel serological marker in systemic sclerosis. Biochem. Biophys. Res. Commun. 299: 549-554.
10. Jeoung, D., Y. Lim, E. B. Lee, S. Lee, H. Y. Kim, H. Lee, and Y. W. Song. 2004. Identification of autoantibody against poIy(ADP-ribose) polymerase (PARP) fragment as a serological marker in systemic lupus erythematosus. J. Autoimmun. 22: 87-94.
11. Schmits, R., B. Kubuschok, S. Scuster, K. D. Preuss, and M. Pfreundschuh. 2002. Analysis of the B cell repertoire against autoantigens in patients with giant cell arthritis and polymyalgia rheumatica. Clin. Exp. Immunol. 127: 379-385.
12. Barbas-Filho, J. V., M. A. Ferreira, A. Sesso, R. A. Kairalla, C. R. Carvalho, and V. L. Capelozzi. 2001. Evidence of type II pneumocyte apoptosis in the patho-genesis of idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia (UIP). J. Clin. Pathol. 54: 132-138.
13. Uhal, B. D., I. Joshi, W. F. Hughes, C. Ramos, A. Pardo, and M. Selman. 1998. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am. J. Physiol. 275: L1192-L1199.
14. Hagimoto, N., K. Kuwano, H. Miyazaki, R. Kunitake, M. Fujita, M. Kawasaki, Y. Kaneko, Y. Nomoto, and N. Hara. 1997. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 17: 272-278.
15. Lee, C. G., S. J. Cho, M. J. Kang, S. P. Chapoval, P. J. Lee, P. W. Noble, T. Yehualaeshet, B. Lu, R. A. Flavell, J. Milbrandt, et al. 2004. Early growth response gene 1-mediated apoplosis is essential for transforming growth factor β1-induced pulmonary fibrosis. J. Exp. Med. 200: 377-389.
16. Hagimoto, N., K. Kuwano, Y. Nomoto, R. Kunitake, and N. Hara. 1997. Apoptosis and expression of FAS/FAS ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 16: 91-101.
17. Shimizudani, N., H. Murata, H. Keino, S. Kojo, H. Nakamura, Y. Morishima, T. Sakamoto, M. Ohtsuka, K. Sekisawa, M. Sumida, et al. 2002. Conserved CDR3 region of T cell receptor BV gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis. Clin. Exp. Immunol. 129: 140-149.
18. + lung T-cell expansions in pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 163: 1540-1545.
19. Yamamoto, K., H. Sakoda, T. Nakajima, T. Kato, M. Okubo, M. Dohi, Y. Mizushima, and K. Ito. 1992. Accumulation of multiple T cell clonotypes in synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int. Immunol. 4: 1219-1223.
20. Feng, X., T. Chuhjo, C. Sugimori, T. Kotani, X. Lu, A. Takami, H. Takamatsu, H. Yamazaki, and S. Nakao. 2004. Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood 104: 2425-2431.
21. Kita, H., Z. X. Lian, J. Van de Water, X. S. He, S. Natsumura, M. Kplan, V. Luketic, R. L. Coppel, A. A. Ansari, and M. E. Gershwin. 2002. Identification of HLA-A2-restricted CDS cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J. Exp. Med. 195: 113-123.
22. Wucherpfennig, K. W., I. Catz, S. Hausmann, J. L. Strominger, L. Steinman, and K. G. Warren. 1997. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients: identity of key contact residues in the B-cell and T-cell epitopes. J. Clin. Invest. 100: 1114-1122.
23. King, T. E., Jr., U. Costabel, J. F. Cordier, G. A. DoPico, R. M. Bois, D. Lynch, J. P. Lynch, J. Myers, R. Panos, G. Raghu, et al. 2000. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am. J. Respir. Crit. Care Med. 161: 646-664.
24. Akira, M., H. Hamada, M. Sakatani, C. Kobayashi, M. Nishioka, and S. Yamamoto. 1997. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am. J. Roentgenol. 168: 79-83.
25. Yao-Tseng, C., J. S. Matthew, S. Ugur, T. Ozlem, O. G. Ali, T. Solam, W. Barbara, S. Elisabeth, P. Michael, and J. O. Lloyd. 1997. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94: 1914-1918.
26. Matsunaga, Y., Y. Usui, and Y. Yoshizawa. 2003. TA-19, a novel protein antigen of Trichosporon asahii, in summer-type hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 167: 991-998.
27. Capelli, A., M. Lusuardi, S. Carli, and C. F. Donner. 1991. Acid phosphatase (E.C. 3.1.3.2) activity in alveolar macrophages from patients with active sarcoid-osis. Chest 99: 545-550.
28. Langerak, A. W., R. Beemd, I. L. Wolvers-Tettero, P. P. Boor, E. G. van Lochcm, H. Hooijkaas, and J. J. van Dongen. 2001. Molecular and flow cytometric analysis of the Vβ repertoire for clonality assessment in mature TCRα7BETA; T-cell proliferations. Blood 98: 165-173.
29. Lefranc, M. P., G. Giudicelli, C. Ginestoux, J. Bodmer, W. Muller, R. Bontrop, M. Lemaitre, A. Malik, V. Barbie, and D. Chaume. 1999. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 27: 209-212.
30. Rescher, U., V. Goebeler, A. Wibers, and V. Gerke. 2006. Proteolytic cleavage of annexin 1 by human leukocyte elastase. Biochim. Biophys. Acta 1763: 1320-1324.
31. Robinson, C., M. Callow, S. Stevenson, B. W. Robinson, and R. A. Lake. 2001. Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis. Respir. Res. 2: 119-124.
32. Savill, J., V. Fadok, P. Henson, and C. Haslett. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14: 131-136.
33. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330.
34. Mevorach, D., J. L. Zhou, X. Song, and K. B. Elkon. 1998. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188: 387-392.
35. Golan, T. D., K. B. Elkon, A. E. Gharavi, and J. G. Krueger. 1992. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic erythematosus patients after ultraviolet B/ultraviolet A irradiation. J. Clin. Invest. 90: 1067-1076.
36. Gensler, T. J., M. Hottelet, and C. Zhang. 2001. Monoclonal antibodies derived from BALB/c mice immunized with apoptotic Jurkat T cells recognize known autoantigens. J. Autoimmun. 16: 59-69.
37. Wang, L., J. F. Scabilloni, J. M. Antonini, Y. Rojanasakul, V. Castranova, and R. R. Mercer. 2006. Induction of secondary apoptosis, inflammation, and lung fibrosis after intratracheal instillation of apoptotic cells in rats. Am. J. Physiol. 290: L695-L702.
38. Raynal, P., and H. B. Pollard. 1994. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipids-binding proteins. Biochim. Biophys. Acta 1197: 63-93.
39. 2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. Nat. Med. 8: 480-484.
40. Hayes, M. J., and S. E. Moss. 2004. Annexins and disease. Biochem. Biophys. Res. Commun. 322: 1166-1170.
41. Walther, A., K. Riehemann, and V. Gerke. 2000. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell. 5: 831-840.
42. Xu, Q., and J. C. Reed. 1998. Bax-inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell. 1: 337-346.
43. Chae, H. J., H. R. Kim, C. Xu, B. Bailly-Maitre, M. Krajewska, S. Krajewski, S. Banares, J. Cui, M. Digicaylioglu, N. Ke, et al. 2004. B-I regulates an apoptosis pathway linked to endoplasmic jeticulum stress. Mol. Cell. 15: 355-366.
44. Kuwano, K., N. Hagimoto, T. Maeyama, M. Fujita, M. Yoshimi, I. Inoshima, N. Nakashima, N. Hamada, K. Watanabe, and N. Hara. 2002. Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab. Invest. 82: 1695-1706.
45. Stumiolo, T., E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, U. Sahin, M. Braxenthaler, F. Gallazzi, M. P. Protti, F. Sinigalia, and J. Hammer. 1999. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17: 555-561.
46. Hammer, J., T. Stumiolo, and F. Sinigaglia. 1997. HLA class II peptide binding specificity and autoimmunity. Adv. Immunol. 66: 67-100.
47. Tsao, F. H., K. C. Meyer, X. Chen, N. S. Rosenthal, and J. Hu. 1998. Degradation of annexin I in bronchoalveolar Iavage fluid from patients with cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 18: 120-128.
48. 2 in the lungs of a mouse model of asthma. Proteomics 4: 3328-3334.